About Campbell Murray, M.D.:

Dr. Campbell Murray is a seasoned biotech investor, operator, and physician with over two decades of experience in venture capital, biotechnology leadership, and clinical medicine. As Co-Founder and Managing Partner of Double Point Ventures, he leads investments in breakthrough life sciences companies, shaping their trajectory from inception through clinical development, regulatory approvals, and commercial success.

Prior to Double Point Ventures, Dr. Murray was a Senior Partner at Bioluminescence Ventures, an advisor to Double Point Ventures, and a General Partner at Agent Capital, where he spearheaded transformative biotech investments. He previously spent more than 15 years at Novartis Venture Fund (NVF), where as a Managing Director, he deployed over $200 million across a high-performing portfolio, driving six M&A exits and eleven IPOs. Over his investment career, Dr. Murray has deployed more than $500 million into biotech startups, supporting their growth from early-stage R&D to successful exits. His strategic vision and ability to scale innovative biotech companies have established him as a leading investor in emerging therapeutics and platform technologies.

Beyond investing, Dr. Murray brings hands-on operational expertise, having served as President & COO of Diabetes Free and Intima Bioscience, where he guided both companies through critical growth phases. A trusted board leader and advisor, he has served on the boards of 25 biotechnology companies, helping navigate clinical development, strategic partnerships, and financings.

Dr. Murray’s expertise spans company creation, early-stage and growth capital investing, and corporate strategy, with a deep focus on advancing groundbreaking innovations in biotechnology and life sciences.